Ibrance 125 mg/1

Ibrance 125 mg is a palbociclib tablet used in cancer treatment. Learn about its uses, effects, and precautions for safe handling.

Ibrance 125 mg is a medication containing palbociclib, a type of CDK4/6 inhibitor. It is commonly used in combination with other treatments for certain types of cancer. The primary use of Ibrance is to help manage and slow the progression of advanced breast cancer in postmenopausal women. It works by targeting specific proteins involved in cell division, which can help control the growth of cancer cells. Understanding what is Ibrance used for involves recognizing its role in targeted cancer therapy.

Common effects of Ibrance 125 mg may include fatigue, nausea, and low blood cell counts. Some individuals might experience hair loss or infections. These effects can vary from person to person, and it's important to monitor any changes while taking this medication. Always consult a healthcare provider for personalized advice.

Handling Ibrance 125 mg requires careful attention to safety. It should be stored at room temperature and kept out of reach of children. Follow the prescribed dosage and administration guidelines provided by your healthcare provider. Regular blood tests may be necessary to monitor for potential side effects. Always inform your healthcare provider about any other medications you are taking.

Ibrance 125 mg may interact with certain medications, including strong CYP3A inhibitors and inducers. It's important to avoid grapefruit products, as they can affect how the body processes palbociclib. Always inform your healthcare provider about all medications, supplements, and herbal products you are taking to avoid potential interactions.